Keeping you up to date on recent developments in diagnostics, including: Urine offers early clues to cancer, Improving detection of esophageal cancer; PanFAM-1 study nears completion.
Researchers at Thomas Jefferson University have implanted brain electrodes in a patient who suffered a subcortical ischemic stroke more than a year ago to help them overcome abnormal muscle tone and control a robotic arm brace. Artificial intelligence (AI) algorithms interpret neuronal signals recorded by the electrodes into movement of the brace.
Keeping you up to date on recent developments in orthopedics, including: Radioactive bone cement may be safer in treating spinal tumors; Unlocking the mystery behind skeletal aging; Sweet coating for sour bones.
Keeping you up to date on recent developments in oncology, including: CD161 identified as impediment to immune response in diffuse glioma; iPSCs give sneak preview of AML; A role for chloroquine in cancer; Fecal transplant may aid in response to immunotherapy in melanoma.
Keeping you up to date on recent developments in neurology, including: Understanding ‘brain fog’ in people with COVID-19; AD diagnostics could become more accessible; Careful with that BBB.
As of the end of January, SARS-CoV-2 has demonstrably infected more than 100 million individuals globally. It has killed more than 2 million. And the long-term sequelae of COVID infections – to say nothing of the health consequences of grief, social isolation and widespread economic distress – are still unfolding and will be for years to come.
Keeping you up to date on recent developments in diagnostics, including: Prostate cancer risk scores; Predicting phase separation; iPSCs give sneak preview of AML.
Keeping you up to date on recent developments in orthopedics, including: Hot nano-chisel used to create artificial bones in a Petri dish; A 'skeletal age' calculator to predict bone fracture risk; Fetal surgery for spina bifida leads to better mobility in school-age children.
KRAS is the most frequently mutated oncogene in solid tumors in general, and in lung tumors in particular. There are more patients whose lung tumors are driven by KRAS mutations than by ALK, Ros, Ret and TRK alterations. Combined. And after 40 years, they look to be getting a targeted therapy, or even two.
Keeping you up to date on recent developments in oncology, including: Less fractionation, fewer trips not a problem for some high-risk prostate cancers; PCOS passed on in the epigenes; Algorithm uses ultrasound images for classification.
RSS
